Skip to content

Trv Gp IV, LLC 13F Holdings · Q2 2026

Trv Gp IV, LLC reported 2 securities worth $253.68M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: MAZE (52.63%), TNGX (47.37%).

RankTickerCompanyValue% PortfolioSharesAction
1MAZEMAZE THERAPEUTICS, INC.$133.5M52.63%4.5MHold
2TNGXTANGO THERAPEUTICS, INC.$120.2M47.37%6.4MHold

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR